Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Careers
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Hospital Solutions
  • Business Intelligence and Data Science
  • Commercial Services for Optimal Performance
  • Commercial Engagement Services
  • Commercial Support Solutions
  • Commercial Technologies
  • Real World Evidence
  • Activation Services
  • Clinical Research & Development Solutions
Hospital Solutions

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Overview
Key Solutions for Hospitals
Business Intelligence and Data Science

As part of the global healthcare community, IQVIA Belgium and its BIDS team (Business Intelligence and Data Science) continuously invest in ways to help life science companies find the next breakthrough in improving human health.

Overview
Key Solutions for Bids
Commercial Services for Optimal Performance

Given the dynamic marketplace, your need to rely on sound information has never been greater. You must make fast decisions without delay. Innovate without undue risk. Execute without faltering.

Overview
Key solutions
Commercial Engagement Services

We can help you get your product to patients quickly. This is done by finding the right candidates to help you in assembling a qualitative team that is trained and equipped with the best tools & applications. With the unique IQVIA approach, we can also make sure you target the right healthcare providers.

Overview
Key solutions
Commercial Support Solutions

IQVIA helps our customers generate real world evidence (RWE) to unlock the value of their investment at every stage of the product life cycle.

Overview
Commercial Technologies

Let yourself be guided and get in direct contact with your key partners in your market. With IQVIA Pharm In Touch, IQVIA Dental In Touch, IQVIA MobiRep and integrated services, you will have even more freedom of movement.

Overview
Real World Evidence

IQVIA helps our customers generate real world evidence (RWE) to unlock the value of their investment at every stage of the product life cycle.

Overview
Activation Services

As the essential partner for pharmacists and pharmaceutical companies we offer effective activation services and marketing tools to meet today's challenges. The Activation Services department of IQVIA is specialised in pharmacy communication and puts its expertise at the service of its partners.

Overview
Clinical Research & Development Solutions

Reimagine clinical development by intelligently connecting data, technology and analytics to optimize your trials. The result? Faster decision making, innovation with reduced risk and driving trials without compromise so you can deliver life-changing therapies faster.

Overview
Key solutions
MAIN/Products
Products/
PRODUCTS
  • Pharmaceutical company
Are you a pharmaceuticals ?

IQVIA is a world leader in using data, technology, advanced analytics and human expertise.

Overview
MAIN/Careers
Careers/
Careers Belgium

Why work at IQVIA Belux? Help create a healthier world—start right here where we offer a diverse selection of opportunities.

Learn more
Explore our Roles

We understand that part of your role involves spending a lot of time on the road, which is why at IQVIA we give you the opportunity to schedule your own agenda.

Learn more

Unleash Your Potential

"Join IQVIA Belux and see where your skills can take you.

Apply Now
MAIN/
/

Press Release

HIV Vaccines: Why we can't give up

Dec 21, 2018

December 1 marked the 30th World AIDS Day – a time to appreciate the strong hope and efforts of HIV research, but also to acknowledge the still pressing need for a preventive vaccine to help end the global pandemic that has caused 35 million deaths since the early 1980s.

In an interview recognizing this occasion, IQVIA’s Paul Turner, Medical Strategy Lead, Senior Medical Director, Infectious Diseases, shares his perspective on where we are today, lessons learned along the way, and why we can’t give up.

The main challenges are the complexity and exclusivity of the virus and the communication flows between different influencing bodies on this subject. However, Paul is convinced that the following will get us to the development of the long-awaited vaccine:

 

Quote from Paul Turner

 

IQVIA experts apply the company’s extensive experience in HIV, including 61 global treatment and prevention studies at 2,284 sites and involving 30,170 subjects, to describe progress towards vaccine development.

Read the full interview with Paul at https://www.iqvia.com/en/blogs/2018/11/hiv-vaccines and discover more about the work of IQVIA’s Infectious Diseases and Vaccines Center of Excellence.

Contact Us